SEC Filing Summary: AFH Acquisition X, Inc.
Business Context and Reporting Period
This Form 8-K was filed by AFH Acquisition X, Inc. (not Bone Biologics Corp) on January 21, 2014, reporting an event that occurred on January 16, 2014. The registrant is a Delaware corporation with principal executive offices in Beverly Hills, CA.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a corporate governance change and does not contain financial statement data.
Material Changes
The primary material change reported is the engagement of a new independent registered public accounting firm:
- New Accountant: Anton & Chia ("A&C").
- Effective Date: January 16, 2014.
- Consultation History: The Company confirms that during the two most recent fiscal years and through the engagement date, neither the Company nor its representatives consulted A&C regarding accounting principles, audit opinions, or any matters involving disagreements or reportable events.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the change in certifying accountant.
Investor Verification Checklist
- Verify the identity of the registrant (AFH Acquisition X, Inc.) versus the requested company name (Bone Biologics Corp).
- Confirm the qualifications and registration status of the new auditor, Anton & Chia, with the PCAOB.
- Review subsequent filings to determine if the change in accountant was accompanied by a departure of the previous auditor and the reasons for such departure.
- Check for any pending financial statements or audit opinions that may be affected by this transition.